94 related articles for article (PubMed ID: 18214283)
1. Effect of recombinant interleukin-5, interleukin-3, and eotaxin on apoptosis in eosinophilic granulocytes.
Ryazantseva NV; Novitskii VV; Litvinova LS; Tkachenko SB; Kolobovnikova YV; Zhukova OB; Grigor'eva ES; Suvorova EV; Knutareva EN; Radzivil TT; Chasovskikh NY
Bull Exp Biol Med; 2007 Apr; 143(4):395-8. PubMed ID: 18214283
[TBL] [Abstract][Full Text] [Related]
2. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice.
Rothenberg ME; Ownbey R; Mehlhop PD; Loiselle PM; van de Rijn M; Bonventre JV; Oettgen HC; Leder P; Luster AD
Mol Med; 1996 May; 2(3):334-48. PubMed ID: 8784786
[TBL] [Abstract][Full Text] [Related]
3. [Dysregulation of cooperative interactions of immunocytes and eosinophils in the mechanism of development of eosinophilia in Opisthorhis felineus invasion].
Litvinova LS; Riazantseva NV; Novitskiĭ VV
Med Parazitol (Mosk); 2008; (3):13-7. PubMed ID: 18819423
[TBL] [Abstract][Full Text] [Related]
4. Interactions between eotaxin and interleukin-5 in the chemotaxis of primed and non-primed human eosinophils.
Costa GG; Silva RM; Franco-Penteado CF; Antunes E; Ferreira HH
Eur J Pharmacol; 2007 Jul; 566(1-3):200-5. PubMed ID: 17368616
[TBL] [Abstract][Full Text] [Related]
5. [Cytokine-mediated apoptosis of granulocytes eosinophilicus in eosinophilia].
Litvinova LS; Riazantseva NV; Novitskiĭ VV; Grigor'eva ES
Tsitologiia; 2008; 50(1):67-71. PubMed ID: 18409371
[TBL] [Abstract][Full Text] [Related]
6. Regulatory effects of eotaxin, eotaxin-2, and eotaxin-3 on eosinophil degranulation and superoxide anion generation.
Badewa AP; Hudson CE; Heiman AS
Exp Biol Med (Maywood); 2002 Sep; 227(8):645-51. PubMed ID: 12192108
[TBL] [Abstract][Full Text] [Related]
7. Effect of interleukin-3, interleukin 5 and hyaluronic acid on cultured eosinophils derived from human umbilical cord blood mononuclear cells.
Ohashi H; Takei M; Ide Y; Ishii H; Kita H; Gleich GJ; Ishikawa M; Fukamachi H
Int Arch Allergy Immunol; 1999 Jan; 118(1):44-50. PubMed ID: 9925962
[TBL] [Abstract][Full Text] [Related]
8. Differentiation stages of eosinophils characterized by hyaluronic acid binding via CD44 and responsiveness to stimuli.
Watanabe Y; Hashizume M; Kataoka S; Hamaguchi E; Morimoto N; Tsuru S; Katoh S; Miyake K; Matsushima K; Tominaga M; Kurashige T; Fujimoto S; Kincade PW; Tominaga A
DNA Cell Biol; 2001 Apr; 20(4):189-202. PubMed ID: 11403716
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma.
Mattes J; Yang M; Mahalingam S; Kuehr J; Webb DC; Simson L; Hogan SP; Koskinen A; McKenzie AN; Dent LA; Rothenberg ME; Matthaei KI; Young IG; Foster PS
J Exp Med; 2002 Jun; 195(11):1433-44. PubMed ID: 12045241
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta abrogates the effects of hematopoietins on eosinophils and induces their apoptosis.
Alam R; Forsythe P; Stafford S; Fukuda Y
J Exp Med; 1994 Mar; 179(3):1041-5. PubMed ID: 8113672
[TBL] [Abstract][Full Text] [Related]
11. Effects of human recombinant interleukin 5 and 3 on the differentiation of cord blood-derived eosinophils and basophils.
Ebisawa M; Saito H; Reason DC; Ohno K; Sudo T; Kurihara K; Nagakura T; Iikura Y
Arerugi; 1989 May; 38(5):442-5. PubMed ID: 2589979
[TBL] [Abstract][Full Text] [Related]
12. Induction by interferons of human eosinophil apoptosis and regulation by interleukin-3, granulocyte/macrophage-colony stimulating factor and interleukin-5.
Morita M; Lamkhioued B; Soussi Gounni A; Aldebert D; Delaporte E; Capron A; Capron M
Eur Cytokine Netw; 1996 Dec; 7(4):725-32. PubMed ID: 9010674
[TBL] [Abstract][Full Text] [Related]
13. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice.
Mould AW; Matthaei KI; Young IG; Foster PS
J Clin Invest; 1997 Mar; 99(5):1064-71. PubMed ID: 9062365
[TBL] [Abstract][Full Text] [Related]
14. Differentiation in vitro of hybrid eosinophil/basophil granulocytes: autocrine function of an eosinophil developmental intermediate.
Boyce JA; Friend D; Matsumoto R; Austen KF; Owen WF
J Exp Med; 1995 Jul; 182(1):49-57. PubMed ID: 7540656
[TBL] [Abstract][Full Text] [Related]
15. A parallel signal-transduction pathway for eotaxin- and interleukin-5-induced eosinophil shape change.
Choi EN; Choi MK; Park CS; Chung IY
Immunology; 2003 Feb; 108(2):245-56. PubMed ID: 12562334
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
Xu J; Jiang F; Nayeri F; Zetterström O
Respir Med; 2007 Jul; 101(7):1447-54. PubMed ID: 17379492
[TBL] [Abstract][Full Text] [Related]
17. alpha4 integrin-dependent eotaxin induction of bronchial hyperresponsiveness and eosinophil migration in interleukin-5 transgenic mice.
Hisada T; Hellewell PG; Teixeira MM; Malm MG; Salmon M; Huang TJ; Chung KF
Am J Respir Cell Mol Biol; 1999 May; 20(5):992-1000. PubMed ID: 10226069
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophils.
Pettipher R; Vinall SL; Xue L; Speight G; Townsend ER; Gazi L; Whelan CJ; Armer RE; Payton MA; Hunter MG
J Pharmacol Exp Ther; 2012 Feb; 340(2):473-82. PubMed ID: 22106101
[TBL] [Abstract][Full Text] [Related]
19. Treatment with topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis.
Lucendo AJ; De Rezende L; Comas C; Caballero T; Bellón T
Am J Gastroenterol; 2008 Sep; 103(9):2184-93. PubMed ID: 18844613
[TBL] [Abstract][Full Text] [Related]
20. The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34+ progenitor cells.
Lamkhioued B; Abdelilah SG; Hamid Q; Mansour N; Delespesse G; Renzi PM
J Immunol; 2003 Jan; 170(1):537-47. PubMed ID: 12496441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
